Ovoca Bio | OVG - Ebitda

Stock Price
8.50
Daily Change
0 0%
Monthly
-34.62%
Yearly
102.38%
Q1 Forecast
9.22

Ovoca Bio reported EUR-5.43M in EBITDA for its fiscal semester ending in June of 2022.





Ebitda Change Date
Akebia Therapeutics USD 14.03M 17.19M Mar/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
ALKERMES USD 100.31M 21.24M Dec/2025
Avita Medical AUD -9.69M 12.21M Dec/2025
Dianthus Therapeutics USD -40.19M 5.36M Sep/2025
Great Western Mining Corporation EUR -529.86K 27.43K Jun/2023
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
IQVIA Holdings USD 1.05B 97M Dec/2025
Malin Corporation EUR -1.1M 200K Dec/2024
Moderna USD -790M 582M Dec/2025
Organon & Co USD 383M 135M Dec/2025
Revvity USD 248.91M 48.52M Dec/2025
Tectonic Therapeutic USD -13.48M 5.73M Dec/2024
Viatris USD 1B 151.5M Dec/2025
Xeris Pharmaceuticals USD 17.42M 8.83M Sep/2025